Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sana Biotechnology, Inc. (SANA)
USD3.15
+0.11 (+3.62%)
US NASDAQ Healthcare Biotechnology
Address
188 East Blaine Street 98102
Seattle, WA, US
Seattle, WA, US
CEO
Steven D. Harr
Website
sana.com
IPO
2021-02-04
CIK 1770121 ISIN US7995661045
Description
Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug candidates includes SG295 and SG242, which are designed to target CD19+ cancer cells involved in non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia. For multiple myeloma, Sana is progressing SG221, SG239, and SC255. Other pipeline assets include SG328 for ornithine transcarbamylase deficiency, and SG418 for sickle cell disease and beta-thalassemia. Additionally, the company is advancing SC291, a CD19 allogeneic T cell therapy, SC451 for type I diabetes mellitus, and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Founded in 2018 as FD Therapeutics, Inc., the company adopted its current name, Sana Biotechnology, Inc., in September 2018 and is based in Seattle, Washington.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.15
+0.11 (+3.62%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4M
Beta
2.16
Float Shares
169.91M
Free Float %
61.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.43% | +7.14% | +0.30% | -21.62% | -23.26% | -18.92% | +50.00% | -45.18% | -84.38% | -90.60% | -90.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
3.15
Low
7.00
+122.2%
Consensus
8.67
+175.2%
Median
7.00
+122.2%
High
12.00
+281.0%
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 3 |
8.67
+175.2%
|
| Last Year | 4 |
8.50
+169.8%
|
| All Time | 6 |
9.00
+185.7%
|
Quality scores
Altman Z-Score
-6.67
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+17.2% Q1'26: +19.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-188.4% Q1'26: -162.1% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+9.7% Q1'26: +16.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.44× Q1'26: -0.53× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 6 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
6.95M
6.95M – 6.95M
|
19.80M
19.80M – 19.80M
+184.9% YoY
|
4.98M
4.98M – 4.98M
-74.9% YoY
|
26.25M
26.25M – 26.25M
+427.6% YoY
|
| EBITDA |
-255.33M
|
-178.21M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-272.72M
|
-190.96M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-266.76M
est: -274.97M (+3.0%)
|
-244.17M
est: -218.56M (-11.7%)
|
-154.95M
-169.94M – -139.95M
+29.1% YoY
|
-135.60M
-161.68M – -109.52M
+12.5% YoY
|
-140.36M
-181.50M – -99.22M
-3.5% YoY
|
-172.20M
-172.20M – -172.20M
-22.7% YoY
|
-157.64M
-157.64M – -157.64M
+8.5% YoY
|
| SGA |
64.04M
|
44.30M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.16
est: -1.19 (+2.2%)
|
-0.96
est: -0.86 (-11.2%)
|
-0.61
-0.67 – -0.55
+29.1% YoY
|
-0.58
-0.64 – -0.43
+5.8% YoY
|
-0.59
-0.72 – -0.39
-2.7% YoY
|
-0.68
-0.68 – -0.68
-14.8% YoY
|
-0.62
-0.62 – -0.62
+8.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
204
Total invested
472.64M
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Robert Nelsen | 44.08M | 23.30% | 36.1K | 44.04M | 36.1K | 44.04M | IN | United States of America | 2022-02-10 | ↗ |
| 2 | ARCH Venture Fund IX Overage, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 3 | ARCH Venture Fund IX, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 4 | ARCH Venture Fund X Overage, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 5 | ARCH Venture Fund X, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 6 | ARCH Venture Partners IX Overage, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 7 | ARCH Venture Partners IX, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 8 | ARCH Venture Partners X Overage, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 9 | ARCH Venture Partners X, L.P. | 44.04M | 23.30% | — | 44.04M | — | 44.04M | PN | Delaware | 2022-02-10 | ↗ |
| 10 | Clinton Bybee | 44.04M | 23.30% | — | 44.04M | — | 44.04M | IN | United States of America | 2022-02-10 | ↗ |
| 11 | Crandell | 44.04M | 23.30% | — | 44.04M | — | 44.04M | IN | United States of America | 2022-02-10 | ↗ |
| 12 | Kristina Burow | 44.04M | 23.30% | — | 44.04M | — | 44.04M | IN | United States of America | 2022-02-10 | ↗ |
| 13 | Steven Gillis | 44.04M | 23.30% | — | 44.04M | — | 44.04M | IN | United States of America | 2022-02-10 | ↗ |
| 14 | (1) BlackRock, Inc. | 11.82M | 5.30% | — | — | 11.82M | — | HC | Delaware | 2024-10-22 | ↗ |
| 15 | Baillie Gifford & Co (Scottish partnership) | 11.26M | 11.00% | — | — | — | — | IA | SCOTLAND UK | 2022-01-26 | ↗ |
| 16 | Canada Pension Plan Investment Board | 10.18M | 5.40% | 10.18M | — | — | — | FI | : | 2022-02-14 | ↗ |
| 17 | Abigail P. Johnson | 9.71M | 5.07% | — | — | 9.71M | — | IN | Delaware | 2023-04-26 | ↗ |
| 18 | FMR LLC | 9.71M | 5.07% | 9.70M | — | 9.71M | — | HC | Delaware | 2023-04-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
204
-4 vs prev Q
New positions
30
Closed positions
34
Increased
97
Reduced
54
Put/Call ratio
0.44
Calls held
337.2K
Puts held
148.5K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 64.9K +64.9K (+100.0%) | 264.17M +264.2M (+100.0%) | 0.02% +0.025 pp | 0.10% +0.104 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 37.43M -1.1K (0.0%) | 152.34M +19.5M (+14.6%) | 14.37% -1.332 pp | 0.01% +0.001 pp | USD11.49 -64.6% | 20 qtrs — |
| 3 | FLAGSHIP PIONEERING INC. | 25.00M +— (+0.0%) | 101.76M +13.0M (+14.6%) | 9.60% -0.889 pp | 31.40% +1.071 pp | USD33.47 -87.8% | 20 qtrs — |
| 4 | BLACKROCK, INC. | 14.22M +3.0M (+26.7%) | 57.89M +18.0M (+45.3%) | 5.46% +0.751 pp | 0.00% +0.000 pp | USD4.11 -1.0% | 6 qtrs — |
| 5 | VANGUARD GROUP INC | 10.46M +1.3M (+14.5%) | 42.55M +10.1M (+31.3%) | 4.01% +0.185 pp | 0.00% +0.000 pp | USD14.09 -71.1% | 20 qtrs — |
| 6 | CANADA PENSION PLAN INVESTMENT BOARD | 10.24M +67.1K (+0.7%) | 41.69M +5.6M (+15.4%) | 3.93% -0.336 pp | 0.03% +0.003 pp | USD33.28 -87.8% | 20 qtrs — |
| 7 | STATE STREET CORP | 8.05M +1.4M (+20.6%) | 32.78M +9.1M (+38.2%) | 3.09% +0.290 pp | 0.00% +0.000 pp | USD6.01 -32.3% | 20 qtrs — |
| 8 | BAILLIE GIFFORD & CO | 6.61M -4.8M (-42.2%) | 26.90M -13.7M (-33.7%) | 2.54% -2.260 pp | 0.02% -0.008 pp | USD27.28 -85.1% | 20 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 4.12M +694.6K (+20.3%) | 16.76M +4.6M (+37.9%) | 1.58% +0.145 pp | 0.00% +0.000 pp | USD12.27 -66.8% | 20 qtrs — |
| 10 | MAREX GROUP PLC | 3.73M -90.0K (-2.4%) | 15.19M +1.6M (+11.9%) | 1.43% -0.171 pp | 0.10% 0.000 pp | USD2.73 +49.1% | 3 qtrs — |
| 11 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 3.00M +1.0M (+50.0%) | 12.21M +5.1M (+72.0%) | 1.15% +0.313 pp | 0.61% +0.126 pp | USD5.43 -25.0% | 8 qtrs — |
| 12 | ALPHABET INC. | 2.81M +— (+0.0%) | 11.45M +1.5M (+14.6%) | 1.08% -0.100 pp | 0.44% +0.029 pp | USD33.47 -87.8% | 20 qtrs — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 1.69M -301.4K (-15.1%) | 6.88M -190.5K (-2.7%) | 0.65% -0.187 pp | 0.01% +0.001 pp | USD3.47 +17.3% | 19 qtrs — |
| 14 | BALYASNY ASSET MANAGEMENT L.P. | 1.68M +1.7M (+100.0%) | 6.83M +6.8M (+100.0%) | 0.64% +0.645 pp | 0.01% +0.009 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 15 | TWO SIGMA INVESTMENTS, LP | 1.58M +969.6K (+158.9%) | 6.43M +4.3M (+196.8%) | 0.61% +0.351 pp | 0.01% +0.006 pp | USD3.56 +14.3% | 17 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 1.49M +806.3K (+118.2%) | 6.06M +3.6M (+150.2%) | 0.57% +0.285 pp | 0.00% +0.000 pp | USD4.51 -9.8% | 20 qtrs — |
| 17 | NORTHERN TRUST CORP | 1.41M +89.2K (+6.8%) | 5.73M +1.0M (+22.4%) | 0.54% -0.013 pp | 0.00% +0.000 pp | USD12.81 -68.2% | 20 qtrs — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.40M +126.8K (+10.0%) | 5.70M +1.2M (+26.1%) | 0.54% +0.003 pp | 0.00% +0.000 pp | USD12.32 -67.0% | 20 qtrs — |
| 19 | WOODLINE PARTNERS LP | 1.32M -60.6K (-4.4%) | 5.36M +470.1K (+9.6%) | 0.51% -0.072 pp | 0.02% -0.002 pp | USD6.31 -35.5% | 20 qtrs — |
| 20 | MORGAN STANLEY | 1.29M +408.5K (+46.6%) | 5.23M +2.1M (+68.1%) | 0.49% +0.126 pp | 0.00% +0.000 pp | USD5.90 -31.0% | 20 qtrs — |
| 21 | CRESTLINE MANAGEMENT, LP | 1.22M -600.0K (-33.0%) | 4.97M -1.5M (-23.1%) | 0.47% -0.295 pp | 9.32% -1.810 pp | USD18.45 -77.9% | 19 qtrs — |
| 22 | BANK OF AMERICA CORP /DE/ | 1.19M +268.6K (+29.3%) | 4.83M +1.6M (+48.2%) | 0.46% +0.071 pp | 0.00% +0.000 pp | USD4.38 -7.1% | 20 qtrs — |
| 23 | UBS GROUP AG | 1.18M -261.0K (-18.1%) | 4.81M -311.5K (-6.1%) | 0.45% -0.152 pp | 0.00% +0.000 pp | USD3.12 +30.4% | 20 qtrs — |
| 24 | AQR CAPITAL MANAGEMENT LLC | 1.13M -47.5K (-4.0%) | 4.62M +421.4K (+10.0%) | 0.44% -0.060 pp | 0.00% 0.000 pp | USD2.41 +68.9% | 9 qtrs — |
| 25 | OMEGA FUND MANAGEMENT, LLC | 843.8K +— (+0.0%) | 3.43M +438.8K (+14.6%) | 0.32% -0.030 pp | 1.20% -0.149 pp | USD33.47 -87.8% | 20 qtrs — |
| 26 | JPMORGAN CHASE & CO | 815.5K -1.3M (-61.8%) | 3.32M -4.3M (-56.2%) | 0.31% -0.583 pp | 0.00% 0.000 pp | USD10.62 -61.7% | 20 qtrs — |
| 27 | PRICE T ROWE ASSOCIATES INC /MD/ | 766.5K +620.4K (+424.6%) | 3.12M +2.6M (+501.3%) | 0.29% +0.233 pp | 0.00% +0.000 pp | USD5.11 -20.4% | 20 qtrs — |
| 28 | GREAT POINT PARTNERS LLC | 700.0K +— (+0.0%) | 2.85M +364.0K (+14.6%) | 0.27% -0.025 pp | 0.92% -0.101 pp | USD3.55 +14.6% | 2 qtrs — |
| 29 | ARROWMARK COLORADO HOLDINGS LLC | 685.1K +— (+0.0%) | 2.79M +356.3K (+14.6%) | 0.26% -0.024 pp | 0.06% +0.016 pp | USD3.94 +3.3% | 10 qtrs — |
| 30 | JANE STREET GROUP, LLC | 668.9K +438.3K (+190.0%) | 2.72M +1.9M (+232.5%) | 0.26% +0.160 pp | 0.00% +0.000 pp | USD3.74 +8.8% | 15 qtrs — |
| 31 | CI PRIVATE WEALTH, LLC | 638.4K -178.6K (-21.9%) | 2.60M -302.2K (-10.4%) | 0.25% -0.098 pp | 0.00% -0.001 pp | USD2.77 +46.9% | 13 qtrs — |
| 32 | MILLENNIUM MANAGEMENT LLC | 623.2K -996.8K (-61.5%) | 2.54M -3.2M (-55.9%) | 0.24% -0.440 pp | 0.00% -0.001 pp | USD3.03 +34.3% | 17 qtrs — |
| 33 | DEUTSCHE BANK AG\ | 562.3K +19.0K (+3.5%) | 2.29M +359.9K (+18.7%) | 0.22% -0.012 pp | 0.00% +0.000 pp | USD6.00 -32.2% | 20 qtrs — |
| 34 | INVESCO LTD. | 561.8K +109.1K (+24.1%) | 2.29M +679.4K (+42.3%) | 0.22% +0.026 pp | 0.00% +0.000 pp | USD3.20 +27.2% | 20 qtrs — |
| 35 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 559.8K +46.2K (+9.0%) | 2.28M +455.2K (+25.0%) | 0.21% -0.001 pp | 0.00% +0.000 pp | USD2.98 +36.6% | 19 qtrs — |
| 36 | BARCLAYS PLC | 509.9K +191.0K (+59.9%) | 2.08M +748.6K (+56.4%) | 0.20% +0.062 pp | 0.00% +0.000 pp | USD3.76 +8.2% | 16 qtrs — |
| 37 | BANK OF NEW YORK MELLON CORP | 457.2K +51.6K (+12.7%) | 1.86M +420.8K (+29.2%) | 0.18% +0.005 pp | 0.00% +0.000 pp | USD12.91 -68.5% | 20 qtrs — |
| 38 | SWISS NATIONAL BANK | 335.8K +73.5K (+28.0%) | 1.37M +435.5K (+46.8%) | 0.13% +0.019 pp | 0.00% +0.000 pp | USD3.66 +11.2% | 17 qtrs — |
| 39 | SQUAREPOINT OPS LLC | 331.7K +109.4K (+49.2%) | 1.35M +560.9K (+71.1%) | 0.13% +0.034 pp | 0.00% +0.001 pp | USD3.92 +3.8% | 17 qtrs — |
| 40 | NUVEEN, LLC | 325.2K +21.2K (+7.0%) | 1.32M +244.3K (+22.6%) | 0.12% -0.003 pp | 0.00% +0.000 pp | USD1.84 +121.2% | 4 qtrs — |
| 41 | BAKER BROS. ADVISORS LP | 310.5K -1.7M (-84.7%) | 1.26M -5.9M (-82.5%) | 0.12% -0.733 pp | 0.01% -0.045 pp | USD4.37 -6.9% | 12 qtrs — |
| 42 | PRIVATE ADVISOR GROUP, LLC | 309.4K +309.4K (+100.0%) | 1.26M +1.3M (+100.0%) | 0.12% +0.119 pp | 0.01% +0.006 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 43 | DEKABANK DEUTSCHE GIROZENTRALE | 112.3K +— (+0.0%) | 1.22M +13.0K (+1.1%) | 0.04% -0.004 pp | 0.00% +0.000 pp | USD15.82 -74.3% | 19 qtrs — |
| 44 | RAFFERTY ASSET MANAGEMENT, LLC | 274.2K +6.2K (+2.3%) | 1.12M +164.5K (+17.3%) | 0.11% -0.007 pp | 0.00% +0.001 pp | USD3.56 +14.3% | 19 qtrs — |
| 45 | UBS ASSET MANAGEMENT AMERICAS INC | 240.4K +99.8K (+70.9%) | 978.5K +479.2K (+96.0%) | 0.09% +0.033 pp | 0.00% +0.000 pp | USD3.77 +8.0% | 17 qtrs — |
| 46 | IEQ CAPITAL, LLC | 236.7K -3.2K (-1.3%) | 963.3K +111.8K (+13.1%) | 0.09% -0.010 pp | 0.00% +0.000 pp | USD2.27 +79.3% | 5 qtrs — |
| 47 | TWO SIGMA ADVISERS, LP | 221.7K +221.7K (+100.0%) | 902.2K +902.2K (+100.0%) | 0.09% +0.085 pp | 0.00% +0.002 pp | USD4.07 +0.0% | 17 qtrs — |
| 48 | CITADEL ADVISORS LLC | 207.9K +105.9K (+103.8%) | 846.2K +484.1K (+133.7%) | 0.08% +0.037 pp | 0.00% +0.000 pp | USD3.61 +12.7% | 15 qtrs — |
| 49 | WELLS FARGO & COMPANY/MN | 191.1K +84.7K (+79.6%) | 777.7K +400.1K (+106.0%) | 0.07% +0.029 pp | 0.00% +0.000 pp | USD3.70 +10.0% | 20 qtrs — |
| 50 | RHUMBLINE ADVISERS | 189.4K -6.3K (-3.2%) | 770.9K +76.2K (+11.0%) | 0.07% -0.009 pp | 0.00% +0.000 pp | USD12.91 -68.5% | 20 qtrs — |
| 51 | ALLIANCEBERNSTEIN L.P. | 186.9K -9.8K (-5.0%) | 760.9K +62.4K (+8.9%) | 0.07% -0.011 pp | 0.00% +0.000 pp | USD12.89 -68.4% | 20 qtrs — |
| 52 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 167.5K +— (+0.0%) | 681.7K +87.1K (+14.6%) | 0.06% -0.006 pp | 0.01% +0.001 pp | USD2.73 +49.1% | 3 qtrs — |
| 53 | CLARIUS GROUP, LLC | 166.1K -46.4K (-21.9%) | 675.9K -78.5K (-10.4%) | 0.06% -0.025 pp | 0.04% -0.006 pp | USD3.38 +20.4% | 19 qtrs — |
| 54 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 164.8K +36.1K (+28.1%) | 670.7K +213.9K (+46.8%) | 0.06% +0.009 pp | 0.00% +0.000 pp | USD4.28 -4.9% | 20 qtrs — |
| 55 | VOYA INVESTMENT MANAGEMENT LLC | 163.5K +138.5K (+554.1%) | 665.6K +576.8K (+649.9%) | 0.06% +0.052 pp | 0.00% +0.001 pp | USD5.20 -21.7% | 20 qtrs — |
| 56 | CITIGROUP INC | 154.8K +70.0K (+82.7%) | 629.9K +329.1K (+109.4%) | 0.06% +0.024 pp | 0.00% +0.000 pp | USD4.01 +1.5% | 20 qtrs — |
| 57 | LEGAL & GENERAL GROUP PLC | 151.0K +21.8K (+16.8%) | 614.6K +155.8K (+33.9%) | 0.06% +0.004 pp | 0.00% +0.000 pp | USD5.10 -20.2% | 20 qtrs — |
| 58 | DIMENSIONAL FUND ADVISORS LP | 133.1K -645.0K (-82.9%) | 541.6K -2.2M (-80.4%) | 0.05% -0.275 pp | 0.00% -0.001 pp | USD5.24 -22.3% | 15 qtrs — |
| 59 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 130.3K -34.8K (-21.1%) | 530.4K -55.6K (-9.5%) | 0.05% -0.019 pp | 0.00% 0.000 pp | USD5.37 -24.2% | 7 qtrs — |
| 60 | STATE OF WISCONSIN INVESTMENT BOARD | 128.9K -69.3K (-35.0%) | 524.4K -179.1K (-25.5%) | 0.05% -0.034 pp | 0.00% 0.000 pp | USD3.55 +14.6% | 19 qtrs — |
| 61 | PALUMBO WEALTH MANAGEMENT LLC | 121.0K +9.7K (+8.7%) | 492.4K +97.3K (+24.6%) | 0.05% 0.000 pp | 0.12% -0.005 pp | USD3.04 +33.9% | 3 qtrs — |
| 62 | VIRTU FINANCIAL LLC | 119.3K +78.1K (+189.4%) | 486.0K +340.0K (+232.9%) | 0.05% +0.029 pp | 0.02% +0.011 pp | USD3.73 +9.1% | 3 qtrs — |
| 63 | XTX TOPCO LTD | 117.4K +10.6K (+9.9%) | 477.7K +98.6K (+26.0%) | 0.05% +0.000 pp | 0.01% -0.007 pp | USD3.60 +13.1% | 2 qtrs — |
| 64 | PROFUND ADVISORS LLC | 102.0K +44.3K (+76.8%) | 415.3K +210.4K (+102.7%) | 0.04% +0.015 pp | 0.01% +0.006 pp | USD3.78 +7.7% | 12 qtrs — |
| 65 | SG AMERICAS SECURITIES, LLC | 98.3K -2.0K (-2.0%) | 400.0K +44.0K (+12.4%) | 0.04% -0.004 pp | 0.00% -0.001 pp | USD1.97 +106.6% | 5 qtrs — |
| 66 | GILDER GAGNON HOWE & CO LLC | 94.1K +2.5K (+2.8%) | 382.9K +57.9K (+17.8%) | 0.04% -0.002 pp | 0.00% +0.001 pp | USD3.56 +14.3% | 2 qtrs — |
| 67 | METLIFE INVESTMENT MANAGEMENT, LLC | 93.1K +14.1K (+17.9%) | 379.0K +98.6K (+35.1%) | 0.04% +0.003 pp | 0.00% +0.001 pp | USD5.15 -21.0% | 20 qtrs — |
| 68 | HSBC HOLDINGS PLC | 94.1K +15.8K (+20.2%) | 374.8K +105.7K (+39.3%) | 0.04% +0.003 pp | 0.00% +0.000 pp | USD3.34 +21.9% | 10 qtrs — |
| 69 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 92.0K +44.5K (+93.6%) | 374.7K +206.1K (+122.2%) | 0.04% +0.015 pp | 0.00% +0.000 pp | USD6.26 -35.0% | 19 qtrs — |
| 70 | MARSHALL WACE, LLP | 88.8K +88.8K (+100.0%) | 361.4K +361.4K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 71 | CWM, LLC | 85.1K -9.0 (0.0%) | 346.0K +44.0K (+14.6%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD2.26 +80.1% | 5 qtrs — |
| 72 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 82.4K +33.0K (+66.7%) | 335.3K +159.9K (+91.1%) | 0.03% +0.011 pp | 0.00% +0.000 pp | USD3.76 +8.2% | 17 qtrs — |
| 73 | SCS CAPITAL MANAGEMENT LLC | 81.3K -70.0 (-0.1%) | 330.7K +42.0K (+14.5%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD1.68 +142.3% | 4 qtrs — |
| 74 | TD ASSET MANAGEMENT INC | 80.6K +80.6K (+100.0%) | 328.0K +328.0K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD4.07 +0.0% | 20 qtrs — |
| 75 | VIRGINIA RETIREMENT SYSTEMS ET AL | 77.4K +77.4K (+100.0%) | 314.8K +314.8K (+100.0%) | 0.03% +0.030 pp | 0.00% +0.002 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 76 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 70.6K +70.6K (+100.0%) | 287.4K +287.4K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.003 pp | USD4.07 +0.0% | 7 qtrs — |
| 77 | FRANKLIN RESOURCES INC | 69.4K -23.7K (-25.4%) | 282.5K -48.0K (-14.5%) | 0.03% -0.012 pp | 0.00% +0.000 pp | USD3.44 +18.3% | 11 qtrs — |
| 78 | NEWEDGE ADVISORS, LLC | 64.4K -33.2K (-34.0%) | 262.1K -84.5K (-24.4%) | 0.02% -0.016 pp | 0.00% -0.001 pp | USD3.26 +24.8% | 4 qtrs — |
| 79 | D. E. SHAW & CO., INC. | 60.9K +60.9K (+100.0%) | 247.9K +247.9K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD4.07 +0.0% | 6 qtrs — |
| 80 | CREATIVE PLANNING | 60.9K +6.7K (+12.4%) | 247.9K +55.5K (+28.9%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD2.00 +103.5% | 5 qtrs — |
| 81 | QUINN OPPORTUNITY PARTNERS LLC | 60.1K -60.0K (-50.0%) | 244.6K -181.7K (-42.6%) | 0.02% -0.027 pp | 0.01% -0.020 pp | USD1.68 +142.3% | 4 qtrs — |
| 82 | ALGERT GLOBAL LLC | 60.0K +60.0K (+100.0%) | 244.0K +244.0K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.004 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 83 | SRS CAPITAL ADVISORS, INC. | 59.0K -106.1K (-64.3%) | 240.2K -365.9K (-60.4%) | 0.02% -0.047 pp | 0.01% -0.002 pp | USD3.55 +14.6% | 2 qtrs — |
| 84 | JANUS HENDERSON GROUP PLC | 58.2K +— (+0.0%) | 236.5K +30.3K (+14.7%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD3.55 +14.6% | 16 qtrs — |
| 85 | BIT CAPITAL GMBH | 58.0K +58.0K (+100.0%) | 236.1K +236.1K (+100.0%) | 0.02% +0.022 pp | 0.01% +0.009 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 86 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 53.1K +199.0 (+0.4%) | 231.4K +13.6K (+6.2%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD2.17 +87.6% | 4 qtrs — |
| 87 | SCHONFELD STRATEGIC ADVISORS LLC | 55.8K +55.8K (+100.0%) | 227.3K +227.3K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.001 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 88 | AXQ CAPITAL, LP | 55.4K +37.2K (+204.0%) | 225.5K +160.8K (+248.5%) | 0.02% +0.014 pp | 0.05% +0.026 pp | USD3.63 +12.1% | 3 qtrs — |
| 89 | MODUS ADVISORS, LLC | 55.0K +55.0K (+100.0%) | 223.9K +223.9K (+100.0%) | 0.02% +0.021 pp | 0.06% +0.059 pp | USD4.07 +0.0% | 1 qtrs NEW |
| 90 | INTECH INVESTMENT MANAGEMENT LLC | 53.3K -19.4K (-26.6%) | 216.9K -41.0K (-15.9%) | 0.02% -0.010 pp | 0.00% 0.000 pp | USD2.69 +51.3% | 6 qtrs — |
| 91 | VIRTUS INVESTMENT ADVISERS, INC. | 51.8K +7.0K (+15.5%) | 210.6K +51.6K (+32.5%) | 0.02% +0.001 pp | 0.06% +0.012 pp | USD2.28 +78.5% | 4 qtrs — |
| 92 | ARIZONA STATE RETIREMENT SYSTEM | 47.3K +7.4K (+18.4%) | 192.7K +50.7K (+35.7%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD3.63 +12.1% | 17 qtrs — |
| 93 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 44.2K +7.5K (+20.5%) | 180.1K +49.7K (+38.1%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD2.48 +64.1% | 5 qtrs — |
| 94 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 43.4K -1.9K (-4.3%) | 176.7K +15.7K (+9.7%) | 0.02% -0.002 pp | 0.01% +0.000 pp | USD5.40 -24.6% | 14 qtrs — |
| 95 | CERITY PARTNERS LLC | 42.4K +279.0 (+0.7%) | 172.6K +23.0K (+15.4%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD1.68 +142.3% | 5 qtrs — |
| 96 | COLONY GROUP, LLC | 42.2K +11.4K (+37.3%) | 171.6K +62.6K (+57.4%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD2.45 +66.1% | 8 qtrs — |
| 97 | PROSHARE ADVISORS LLC | 42.1K +10.1K (+31.5%) | 171.5K +57.7K (+50.8%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD7.73 -47.3% | 18 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 85 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.88% | 509.0K | 0.65% |
| 2 | WisdomTree BioRevolution UCITS ETF - USD Acc WDNA.L | 0.70% | 156.0K | 0.45% |
| 3 | Global X - S&P Biotech ETF CURE.AX | 0.25% | 91.0K | 0.45% |
| 4 | State Street SPDR S&P Biotech ETF XBI | 0.25% | 27.32M | 0.35% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.07% | 814.3K | 0.35% |
| 6 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.07% | 54.5K | 0.35% |
| 7 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.07% | 341.0K | 0.40% |
| 8 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.07% | 55.0K | 0.19% |
| 9 | Innovator U.S. Small Cap Managed Floor ETF RFLR | 0.06% | 50.9K | 0.89% |
| 10 | iShares Biotechnology ETF IBB | 0.05% | 5.01M | 0.44% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.08
Neutral
Ratio by volume
3.00
Bullish
Buys
13
Sells
12
Shares acquired
2.57M
Shares disposed
146.0K
Cash buys
—
Cash sales
—
Net activity
+2,426,610
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 7,763 | 0.00 | — | 5,848,503 | D | ↗ |
| 2026-03-24 | PATEL DHAVALKUMAR DHIRAJLAL | Officer | — | — | Common Stock | 0 | 0.00 | — | 99,510 | D | ↗ |
| 2026-03-09 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 1,045 | 3.10 | 3.2K | 196,196 | D | ↗ |
| 2026-03-09 | Harr Steve | Director / Officer | F-InKind | D | Common Stock | 11,526 | 3.13 | 36.1K | 7,957,070 | D | ↗ |
| 2026-03-07 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 3,250 | 0.00 | — | 200,583 | D | ↗ |
| 2026-03-07 | Harr Steve | Director / Officer | M-Exempt | D | Restricted Stock Units | 50,000 | 0.00 | — | 100,000 | D | ↗ |
| 2026-03-06 | Wyrick Susan D. | Officer | M-Exempt | D | Restricted Stock Units | 10,416 | 0.00 | — | 31,251 | D | ↗ |
| 2026-03-06 | Harr Steve | Director / Officer | M-Exempt | D | Restricted Stock Units | 41,666 | 0.00 | — | 125,001 | D | ↗ |
| 2026-03-05 | Wyrick Susan D. | Officer | A-Award | A | Stock Option (Right to Buy) | 206,250 | 3.41 | 703.3K | 206,250 | D | ↗ |
| 2026-03-05 | Harr Steve | Director / Officer | A-Award | A | Restricted Stock Units | 200,000 | 0.00 | — | 200,000 | D | ↗ |
| 2026-03-03 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 491 | 3.91 | 1.9K | 186,917 | D | ↗ |
| 2026-03-02 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 1,525 | 0.00 | — | 187,408 | D | ↗ |
| 2026-02-17 | Piper Brian | Officer | A-Award | A | Stock Option (Right to Buy) | 900,000 | 3.85 | 3.47M | 900,000 | D | ↗ |
| 2026-01-05 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 2,407 | 4.27 | 10.3K | 185,883 | D | ↗ |
| 2026-01-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 6,157 | 0.00 | — | 5,840,740 | D | ↗ |
| 2026-01-02 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 188,290 | D | ↗ |
| 2025-12-15 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 873 | 5.22 | 4.6K | 180,790 | D | ↗ |
| 2025-12-13 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 3,400 | 0.00 | — | 181,663 | D | ↗ |
| 2025-12-04 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 2,565 | 4.44 | 11.4K | 178,263 | D | ↗ |
| 2025-12-03 | Wyrick Susan D. | Officer | M-Exempt | D | Restricted Stock Units | 10,000 | 0.00 | — | 0 | D | ↗ |
| 2025-10-06 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 5,628 | 0.00 | — | 5,834,583 | D | ↗ |
| 2025-07-07 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 7,842 | 0.00 | — | 5,828,955 | D | ↗ |
| 2025-06-05 | Yang Patrick Y | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Wilderotter Mary Agnes | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Seitz Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Rosiello Robert L. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-05 | REICIN ALISE | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | NELSEN ROBERT | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Mulligan Richard | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Bishop Hans Edgar | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-05 | Bilenker Joshua H. | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.55 | 204.0K | 80,000 | D | ↗ |
| 2025-06-04 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 2,567 | 2.32 | 6.0K | 167,828 | D | ↗ |
| 2025-06-03 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 10,000 | 0.00 | — | 170,395 | D | ↗ |
| 2025-04-07 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 16,339 | 0.00 | — | 5,821,113 | D | ↗ |
| 2025-03-10 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 836 | 2.56 | 2.1K | 157,395 | D | ↗ |
| 2025-03-10 | Harr Steve | Director / Officer | F-InKind | D | Common Stock | 12,820 | 2.56 | 32.8K | 7,876,930 | D | ↗ |
| 2025-03-10 | Cassidy Bernard J | Officer | F-InKind | D | Common Stock | 2,833 | 2.56 | 7.3K | 112,990 | D | ↗ |
| 2025-03-07 | Wyrick Susan D. | Officer | M-Exempt | D | Restricted Stock Units | 3,250 | 0.00 | — | 9,750 | D | ↗ |
| 2025-03-07 | Harr Steve | Director / Officer | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 7,889,750 | D | ↗ |
| 2025-03-07 | Cassidy Bernard J | Officer | M-Exempt | D | Restricted Stock Units | 11,041 | 0.00 | — | 33,126 | D | ↗ |
| 2025-03-06 | Wyrick Susan D. | Officer | A-Award | A | Stock Option (Right to Buy) | 187,500 | 2.55 | 478.1K | 187,500 | D | ↗ |
| 2025-03-06 | Harr Steve | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 750,000 | 2.55 | 1.91M | 750,000 | D | ↗ |
| 2025-03-06 | Cassidy Bernard J | Officer | A-Award | A | Stock Option (Right to Buy) | 240,000 | 2.55 | 612.0K | 240,000 | D | ↗ |
| 2025-03-03 | Wyrick Susan D. | Officer | F-InKind | D | Common Stock | 490 | 2.56 | 1.3K | 154,981 | D | ↗ |
| 2025-03-02 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 1,525 | 0.00 | — | 155,471 | D | ↗ |
| 2025-01-08 | FMR LLC | 10% Owner | S-Sale | D | Common Stock | 100,000 | 6.11 | 611.0K | 4,732,423 | I | ↗ |
| 2025-01-06 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 14,285 | 0.00 | — | 5,804,774 | D | ↗ |
| 2025-01-02 | Wyrick Susan D. | Officer | M-Exempt | A | Common Stock | 5,000 | 0.00 | — | 155,512 | D | ↗ |
| 2024-12-13 | Wyrick Susan D. | Officer | A-Award | A | Stock Option (Right to Buy) | 5,100 | 1.89 | 9.6K | 5,100 | D | ↗ |
| 2024-10-07 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 5,938 | 0.00 | — | 5,790,489 | D | ↗ |
| 2024-10-04 | Wyrick Susan D. | Officer | — | — | Stock Option (Right to buy) | 65,000 | 7.80 | 507.0K | 0 | D | ↗ |
| 2024-09-25 | Mulligan Richard | Director | S-Sale | D | Common Stock | 150,000 | 3.89 | 583.2K | 2,698,121 | D | ↗ |
| 2024-09-24 | Mulligan Richard | Director | S-Sale | D | Common Stock | 150,000 | 4.08 | 612.6K | 2,848,121 | D | ↗ |
| 2024-07-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 4,911 | 0.00 | — | 5,784,551 | — | ↗ |
| 2024-06-06 | Yang Patrick Y | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Wilderotter Mary Agnes | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Seitz Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | REICIN ALISE | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | NELSEN ROBERT | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Mulligan Richard | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Cole Douglas G. | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Bishop Hans Edgar | Director | A-Award | A | Stock Option (Right to Buy) | 54,278 | 7.36 | 399.5K | 54,278 | — | ↗ |
| 2024-06-06 | Bilenker Joshua H. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 7.36 | 478.4K | 65,000 | — | ↗ |
| 2024-04-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 2,774 | 0.00 | — | 5,779,640 | — | ↗ |
| 2024-04-01 | FMR LLC | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 61 | I | ↗ |
| 2024-03-08 | Yang Patrick Y | Director | S-Sale | D | Common Stock | 25,000 | 9.45 | 236.3K | 149,250 | — | ↗ |
| 2024-03-07 | WILLIAMS DOUGLAS E | Officer | A-Award | A | Stock Option (Right to Buy) | 301,875 | 9.58 | 2.89M | 301,875 | — | ↗ |
| 2024-03-07 | Hordo Christian | Officer | A-Award | A | Restricted Stock Units | 37,500 | 0.00 | — | 37,500 | — | ↗ |
| 2024-03-07 | Harr Steve | Director / Officer | A-Award | A | Restricted Stock Units | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2024-03-07 | Hardy Nathan | Officer | A-Award | A | Restricted Stock Units | 67,083 | 0.00 | — | 67,083 | — | ↗ |
| 2024-03-07 | Cassidy Bernard J | Officer | A-Award | A | Restricted Stock Units | 44,167 | 0.00 | — | 44,167 | — | ↗ |
| 2024-02-12 | Flagship Pioneering Inc. | 10% Owner | P-Purchase | A | Pre-Funded Warrants to purchase Common Stock | 2,727,272 | 0.00 | 272.73 | 2,727,272 | — | ↗ |
| 2024-02-12 | Flagship Pioneering Fund VII General Partner LLC | 10% Owner | — | I | Pre-Funded Warrants to purchase Common Stock | 2,727,272 | 0.00 | 272.73 | 0 | — | ↗ |
| 2024-02-08 | NELSEN ROBERT | Director / 10% Owner | P-Purchase | A | Common Stock | 363,637 | 5.50 | 2.00M | 10,667,387 | — | ↗ |
| 2024-02-08 | CRANDELL KEITH | 10% Owner | P-Purchase | A | Common Stock | 363,637 | 5.50 | 2.00M | 10,667,387 | — | ↗ |
| 2024-02-08 | ARCH Venture Fund X, L.P. | 10% Owner | P-Purchase | A | Common Stock | 727,272 | 5.50 | 4.00M | 12,446,022 | — | ↗ |
| 2024-01-05 | Wilderotter Mary Agnes | Director | A-Award | A | Common Stock | 1,470 | 0.00 | — | 7,106 | — | ↗ |
| 2024-01-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 4,901 | 0.00 | — | 5,776,866 | — | ↗ |
| 2023-12-15 | Hordo Christian | Officer | S-Sale | D | Common Stock | 75,000 | 4.00 | 300.1K | 867,455 | — | ↗ |
| 2023-11-02 | WILLIAMS DOUGLAS E | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-11-02 | Hordo Christian | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-11-02 | Hardy Nathan | Officer | A-Award | A | Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-10-05 | Wilderotter Mary Agnes | Director | A-Award | A | Common Stock | 2,077 | 0.00 | — | 5,636 | — | ↗ |
| 2023-10-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 6,925 | 0.00 | — | 5,771,965 | — | ↗ |
| 2023-09-13 | Flagship Pioneering Inc. | 10% Owner | J-Other | D | Common Stock | 2,825,989 | 0.00 | — | 8,615,337 | — | ↗ |
| 2023-07-05 | Wilderotter Mary Agnes | Director | A-Award | A | Common Stock | 1,245 | 0.00 | — | 3,559 | — | ↗ |
| 2023-07-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 4,152 | 0.00 | — | 5,765,040 | — | ↗ |
| 2023-06-08 | Yang Patrick Y | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | Wilderotter Mary Agnes | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | Seitz Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | REICIN ALISE | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | NELSEN ROBERT | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | Cole Douglas G. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | Bishop Hans Edgar | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-08 | Bilenker Joshua H. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 6.70 | 435.5K | 65,000 | — | ↗ |
| 2023-06-07 | Flagship Ventures Fund V General Partner LLC | 10% Owner | S-Sale | D | Common Stock | 177,240 | 6.24 | 1.11M | 10,743,293 | — | ↗ |
| 2023-06-06 | Flagship Ventures Fund V General Partner LLC | 10% Owner | S-Sale | D | Common Stock | 181,461 | 6.31 | 1.14M | 10,920,533 | — | ↗ |
| 2023-05-26 | Flagship Ventures Fund V General Partner LLC | 10% Owner | S-Sale | D | Common Stock | 9,330 | 6.23 | 58.1K | 1,425,334 | — | ↗ |
| 2023-05-25 | Flagship Ventures Fund V General Partner LLC | 10% Owner | S-Sale | D | Common Stock | 13,127 | 6.35 | 83.4K | 1,434,664 | — | ↗ |
| 2023-05-24 | Flagship Ventures Fund V General Partner LLC | 10% Owner | S-Sale | D | Common Stock | 308,290 | 6.57 | 2.02M | 11,276,909 | — | ↗ |
| 2023-04-10 | WILLIAMS DOUGLAS E | Officer | A-Award | A | Stock Option (Right to Buy) | 1,100,000 | 3.28 | 3.61M | 1,100,000 | — | ↗ |
| 2023-04-05 | Wilderotter Mary Agnes | Director | A-Award | A | Common Stock | 2,314 | 0.00 | — | 2,314 | — | ↗ |
| 2023-04-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 7,716 | 0.00 | — | 5,760,888 | — | ↗ |
| 2023-03-02 | Mulligan Richard | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 200,000 | 3.76 | 752.0K | 200,000 | — | ↗ |
| 2023-03-02 | Hordo Christian | Officer | A-Award | A | Stock Options (Right to Buy) | 185,000 | 3.76 | 695.6K | 185,000 | — | ↗ |
| 2023-03-02 | Harr Steve | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 650,000 | 3.76 | 2.44M | 650,000 | — | ↗ |
| 2023-03-02 | Hardy Nathan | Officer | A-Award | A | Stock Options (Right to Buy) | 200,000 | 3.76 | 752.0K | 200,000 | — | ↗ |
| 2023-03-02 | Cassidy Bernard J | Officer | A-Award | A | Stock Options (Right to Buy) | 140,000 | 3.76 | 526.4K | 140,000 | — | ↗ |
| 2023-01-05 | NELSEN ROBERT | Director | A-Award | A | Common Stock | 536 | 0.00 | — | 1,353 | — | ↗ |
| 2023-01-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 6,702 | 0.00 | — | 5,753,172 | — | ↗ |
| 2022-10-05 | NELSEN ROBERT | Director | A-Award | A | Common Stock | 321 | 0.00 | — | 817 | — | ↗ |
| 2022-10-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 4,012 | 0.00 | — | 5,746,470 | — | ↗ |
| 2022-07-05 | NELSEN ROBERT | Director | A-Award | A | Common Stock | 266 | 0.00 | — | 496 | — | ↗ |
| 2022-07-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 3,328 | 0.00 | — | 5,742,458 | — | ↗ |
| 2022-06-13 | MacDonald James J. | Director | M-Exempt | A | Common Stock | 66,796 | 1.48 | 98.9K | 497,396 | — | ↗ |
| 2022-06-06 | Yang Patrick Y | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | Wilderotter Mary Agnes | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | Seitz Michelle | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | REICIN ALISE | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | NELSEN ROBERT | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | Cole Douglas G. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 4.95 | 321.8K | 65,000 | — | ↗ |
| 2022-06-06 | Bishop Hans Edgar | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-06-06 | Bilenker Joshua H. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 0.00 | — | 65,000 | — | ↗ |
| 2022-04-05 | NELSEN ROBERT | Director | A-Award | A | Common Stock | 230 | 0.00 | — | 230 | — | ↗ |
| 2022-04-05 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 2,880 | 0.00 | — | 5,739,130 | — | ↗ |
| 2022-03-21 | Yang Patrick Y | Director | P-Purchase | A | Common Stock | 28,000 | 7.30 | 204.4K | 174,250 | — | ↗ |
| 2022-03-03 | Mulligan Richard | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 5.70 | 1.43M | 250,000 | — | ↗ |
| 2022-03-03 | MacDonald James J. | Director | A-Award | A | Stock Options (Right to Buy) | 225,000 | 0.00 | — | 225,000 | — | ↗ |
| 2022-03-03 | Hordo Christian | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 225,000 | 0.00 | — | 225,000 | — | ↗ |
| 2022-03-03 | Harr Steve | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 760,000 | 5.70 | 4.33M | 760,000 | — | ↗ |
| 2022-03-03 | Hardy Nathan | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 225,000 | 0.00 | — | 225,000 | — | ↗ |
| 2022-03-03 | AGARWAL SUNIL | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 5.70 | 1.43M | 250,000 | — | ↗ |
| 2022-02-18 | MacDonald James J. | Officer | S-Sale | D | Common Stock | 333 | 6.28 | 2.1K | 429,417 | — | ↗ |
| 2021-11-15 | MacDonald James J. | Officer | A-Award | A | Common Stock | 1,000 | 18.23 | 18.2K | 429,750 | — | ↗ |
| 2021-09-16 | AGARWAL SUNIL | Officer | S-Sale | D | Common Stock | 1,627 | 26.00 | 42.3K | 1,550,000 | — | ↗ |
| 2021-09-15 | AGARWAL SUNIL | Officer | S-Sale | D | Common Stock | 58,373 | 26.07 | 1.52M | 1,551,627 | — | ↗ |
| 2021-09-10 | Hordo Christian | Officer | S-Sale | D | Common Stock | 1,477 | 25.00 | 36.9K | 942,455 | — | ↗ |
| 2021-09-09 | Hordo Christian | Officer | M-Exempt | A | Common Stock | 39,205 | 1.48 | 58.0K | 1,008,603 | — | ↗ |
| 2021-09-03 | Hordo Christian | Officer | M-Exempt | D | Stock Option (Right to Buy) | 700 | 1.48 | 1.0K | 128,008 | — | ↗ |
| 2021-09-02 | Hordo Christian | Officer | M-Exempt | A | Common Stock | 6,558 | 1.48 | 9.7K | 977,356 | — | ↗ |
| 2021-09-01 | Hordo Christian | Officer | S-Sale | D | Common Stock | 1,134 | 25.00 | 28.4K | 973,800 | — | ↗ |
| 2021-08-30 | Hordo Christian | Officer | S-Sale | D | Common Stock | 1,100 | 25.01 | 27.5K | 975,000 | — | ↗ |
| 2021-04-21 | NELSEN ROBERT | Director / 10% Owner | J-Other | A | Common Stock | 12,500 | 0.00 | — | 12,500 | — | ↗ |
| 2021-04-14 | Harr Steve | Director / Officer | G-Gift | D | Common Stock | 167,000 | 0.00 | — | 7,839,750 | — | ↗ |
| 2021-02-08 | von Maltzahn Geoffrey | Director | C-Conversion | A | Common Stock | 1,464,488 | 0.00 | — | 1,464,488 | — | ↗ |
| 2021-02-08 | NELSEN ROBERT | Director | C-Conversion | D | Series B Convertible Preferred Stock | 2,343,750 | 0.00 | — | 0 | — | ↗ |
| 2021-02-08 | MacDonald James J. | Officer | C-Conversion | D | Series A-1 Convertible Preferred Stock | 93,750 | 0.00 | — | 0 | — | ↗ |
| 2021-02-08 | Harr Steve | Director / Officer | C-Conversion | A | Common Stock | 2,031,250 | 0.00 | — | 8,173,750 | — | ↗ |
| 2021-02-08 | Flagship Ventures Fund V General Partner LLC | 10% Owner | C-Conversion | A | Common Stock | 11,441,326 | 0.00 | — | 11,441,326 | — | ↗ |
| 2021-02-08 | Bishop Hans Edgar | Director | C-Conversion | D | Series A-2 Convertible Preferred Stock | 800,000 | 0.00 | — | 0 | — | ↗ |
| 2021-02-08 | ARCH Venture Fund X, L.P. | 10% Owner | C-Conversion | D | Series A-1 Convertible Preferred Stock | 3,687,500 | 0.00 | — | 0 | I | ↗ |
| 2021-02-03 | von Maltzahn Geoffrey | Director | — | D | Series A-2 Convertible Preferred Stock | 1,464,488 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | Yang Patrick Y | Director | — | D | Common Stock | 0 | 0.00 | — | 146,250 | — | ↗ |
| 2021-02-03 | Wilderotter Mary Agnes | Director | A-Award | A | Stock Option (Right to Buy) | 23,591 | 25.00 | 589.8K | 23,591 | — | ↗ |
| 2021-02-03 | Seitz Michelle | Director | — | D | Stock Option (Right to Buy) | 93,750 | 7.80 | 731.3K | 0 | — | ↗ |
| 2021-02-03 | REICIN ALISE | Director | — | D | Stock Option (Right to Buy) | 93,750 | 7.80 | 731.3K | 0 | — | ↗ |
| 2021-02-03 | NELSEN ROBERT | Director | A-Award | A | Stock Option (Right to Buy) | 14,000 | 25.00 | 350.0K | 14,000 | — | ↗ |
| 2021-02-03 | Mulligan Richard | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 2,998,121 | — | ↗ |
| 2021-02-03 | MacDonald James J. | Officer | — | D | Stock Option (Right to Buy) | 118,750 | 1.48 | 175.8K | 0 | — | ↗ |
| 2021-02-03 | Hordo Christian | Officer | — | D | Common Stock | 0 | 0.00 | — | 975,000 | — | ↗ |
| 2021-02-03 | Harr Steve | Director / Officer | — | D | Series B Convertible Preferred Stock | 156,250 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | Hardy Nathan | Officer | — | D | Stock Option (Right to Buy) | 118,750 | 1.48 | 175.8K | 0 | — | ↗ |
| 2021-02-03 | Flagship Ventures Fund V General Partner LLC | 10% Owner | — | I | Series A-2 Convertible Preferred Stock | 11,585,199 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | Cole Douglas G. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | Bishop Hans Edgar | Director | — | D | Series B Convertible Preferred Stock | 156,250 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | Bilenker Joshua H. | Director | A-Award | A | Stock Option (Right to Buy) | 11,795 | 25.00 | 294.9K | 11,795 | — | ↗ |
| 2021-02-03 | ARCH Venture Fund X, L.P. | 10% Owner | — | I | Series B Convertible Preferred Stock | 2,343,750 | 0.00 | — | 0 | — | ↗ |
| 2021-02-03 | AGARWAL SUNIL | Officer | A-Award | A | Stock Option (Right to Buy) | 48,000 | 25.00 | 1.20M | 48,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
278.29M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | President, Chief Executive Officer, and Director | 696.1K | — | 425.0K | 1.33M | 450.4K | 4.0K | 2.90M | 60.37% | ↗ |
| 2 | 2025 | Former Executive Vice President, General Counsel, and Corporate Secretary | 404.0K | — | 136.0K | 424.8K | — | 51.3K | 1.02M | 55.19% | ↗ |
| 3 | 2024 | President, Chief Executive Officer, and Director | 681.0K | — | 1.92M | 5.86M | 328.6K | 4.0K | 8.79M | 88.47% | ↗ |
| 4 | 2024 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director | 681.0K | — | 1.92M | 5.86M | 328.6K | 4.0K | 8.79M | 88.47% | ↗ |
| 5 | 2024 | Nathan Hardy Former Executive Vice President, Chief Financial Officer | 390.3K | — | 642.7K | 1.97M | — | 52.1K | 3.05M | 85.50% | ↗ |
| 6 | 2024 | Douglas E. Williams, Ph.D. Former Executive Vice President and President, Research and Development | 190.8K | — | 436.7K | 1.97M | — | 161.3K | 2.75M | 87.21% | ↗ |
| 7 | 2024 | Bernard J. Cassidy Executive Vice President, General Counsel, and Corporate Secretary | 472.6K | — | 423.1K | 1.29M | 152.0K | 4.0K | 2.35M | 73.20% | ↗ |
| 8 | 2024 | Former Executive Vice President, General Counsel, and Corporate Secretary | 472.6K | — | 423.1K | 1.29M | 152.0K | 4.0K | 2.35M | 73.20% | ↗ |
| 9 | 2023 | Douglas E. Williams, Ph.D. Former Executive Vice President and President, Research and Development | 412.7K | — | 30.8K | 2.38M | 220.4K | 4.0K | 3.04M | 79.08% | ↗ |
| 10 | 2023 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director | 659.4K | — | — | 1.63M | 377.0K | 4.0K | 2.67M | 61.06% | ↗ |
| 11 | 2023 | Nathan Hardy Executive Vice President, Chief Financial Officer | 468.9K | — | 30.8K | 501.9K | 180.1K | 4.0K | 1.19M | 44.93% | ↗ |
| 12 | 2023 | Nathan Hardy Former Executive Vice President, Chief Financial Officer | 468.9K | — | 30.8K | 501.9K | 180.1K | 4.0K | 1.19M | 44.93% | ↗ |
| 13 | 2023 | Bernard J. Cassidy Executive Vice President, General Counsel, and Corporate Secretary | 457.6K | — | — | 351.3K | 174.4K | 4.0K | 987.4K | 35.58% | ↗ |
| 14 | 2022 | Bernard J. Cassidy Executive Vice President, General Counsel, and Corporate Secretary | 129.8K | — | — | 3.77M | 54.7K | 4.0K | 3.95M | 95.23% | ↗ |
| 15 | 2022 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director | 644.8K | — | — | 2.77M | 389.1K | 4.0K | 3.81M | 72.74% | ↗ |
| 16 | 2022 | Sunil Agarwal, M.D. Former Executive Vice President, Head of Development, and Chief Medical Officer | 530.9K | — | — | 911.2K | 213.5K | 4.0K | 1.66M | 54.91% | ↗ |
| 17 | 2021 | Sunil Agarwal, M.D. Former Executive Vice President, Head of Development, and Chief Medical Officer | 512.6K | 10.0K | — | 1.20M | 205.8K | — | 1.93M | 62.23% | ↗ |
| 18 | 2021 | Sunil Agarwal, M.D. Chief Medical Officer Executive Vice President, | 512.6K | 10.0K | — | 1.20M | 205.8K | — | 1.93M | 62.23% | ↗ |
| 19 | 2021 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director | 611.2K | 200.0K | — | — | 375.0K | — | 1.19M | 0.00% | ↗ |
| 20 | 2021 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director Executive Vice President, Head of Development, and | 611.2K | 200.0K | — | — | 375.0K | — | 1.19M | 0.00% | ↗ |
| 21 | 2021 | Nathan Hardy Chief Financial Officer | 413.5K | 100.0K | — | — | 170.0K | — | 683.5K | 0.00% | ↗ |
| 22 | 2020 | Steven D. Harr, M.D. President, Chief Executive Officer, and Director Executive Vice President, Head of Development, and | 535.0K | — | — | 6.02M | 294.3K | — | 6.85M | 87.89% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Steven D. Harr | President, Chief Executive Officer & Director | 1M | — |
| Brian D. Piper | Executive Vice President & Chief Financial Officer | 653.0K | male |
| Dhavalkumar D. Patel | Executive Vice President & Chief Scientific Officer | — | — |
| Gary Meininger | Chief Medical Officer | — | — |
| John Gerecitano | Head of Oncology Research & Development | — | male |
| Snehal Patel | Senior Vice President & Chief Technical Officer | — | male |
| Susan Wyrick | Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting | — | female |
| Aaron Grossman | Executive VP, Chief Legal Officer & Corporate Secretary | — | male |
| Yuko Soneoka | Head of Intellectual Property | — | — |
| Debra Wisdom | VP & Head of People | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SANA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
